Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
02/12/2015 | US20150044258 Process for t cell expansion |
02/12/2015 | US20150044257 Baculovirus-based enterovirus 71 vlp as a vaccine |
02/12/2015 | US20150044256 Oral Vaccine For Borrelia |
02/12/2015 | US20150044254 Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells |
02/12/2015 | US20150044253 Immunogenic composition |
02/12/2015 | US20150044252 Correlation of disease activity with clonal expansions of human papillomavirus 16-specific cd8+ t-cells in patients with severe erosive oral lichen planus |
02/12/2015 | US20150044251 Stable compositions for immunising against staphylococcus aureus |
02/12/2015 | US20150044250 Vaccines against clostridium difficile comprising recombinant toxins |
02/12/2015 | US20150044249 Polyvalent chimeric ospc vaccinogen and diagnostic antigen |
02/12/2015 | US20150044248 Polypeptides and their use in treating metapneumovirus (mpv) infection |
02/12/2015 | US20150044247 Computationally optimized broadly reactive antigens for h3n2, h2n2, and b influenza viruses |
02/12/2015 | US20150044244 Combined facilitator, antigen and dna vaccine for preventing and treating autoimmune diseases |
02/12/2015 | US20150044243 Mucosal immunization to prevent prion infection |
02/12/2015 | US20150044242 Adjuvant and Vaccine Compositions |
02/12/2015 | US20150044241 Contraceptive vaccines for mammals |
02/12/2015 | US20150044240 P53 vaccines for the treatment of cancers |
02/12/2015 | US20150044238 Methods of using monomethylvaline compositions having phenylalanine carboxy modifications at the c-terminus |
02/12/2015 | US20150044233 Ganglioside gd2 as a marker and target on cancer stem cells |
02/12/2015 | US20150044230 Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells |
02/12/2015 | US20150044229 Methods related to tim 3, a th1-specific cell surface molecule, for activating antigen presenting cells |
02/12/2015 | US20150044228 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
02/12/2015 | US20150044227 Methods of treatment with angiopoietin-2 antibodies |
02/12/2015 | US20150044223 Combination drug therapy for the treatment of solid tumors |
02/12/2015 | US20150044221 Pharmaceutical composition for treatment and/or prevention of cancer |
02/12/2015 | US20150044220 Co-use of a clusterin inhibitor with an egfr inhibitor to treat cancer |
02/12/2015 | US20150044219 Combination of SEMA-4D Inhibitors and Immunomodulators to Inhibit Tumors and Metastases |
02/12/2015 | US20150044218 N-domain of carcinoembryonic antigen and compositions, methods and uses thereof |
02/12/2015 | US20150044213 Protein sustained-release injectable formulation |
02/12/2015 | US20150044211 Combination of a 6-oxo-1,6-dihydro-pyridazine derivative having anti-cancer activity with other anti-tumor compounds |
02/12/2015 | US20150044209 SOLUBLE IGF RECEPTOR Fc FUSION PROTEINS AND USES THEREOF |
02/12/2015 | US20150044207 Clotting Factor-Fc Chimeric Proteins to Treat Hemophilia |
02/12/2015 | US20150044206 Immunoglobulin formulation and method of preparation thereof |
02/12/2015 | US20150044203 Methods For Increasing Forced Expiratory Volume In Asthmatics Using Benralizumab |
02/12/2015 | US20150044201 Cyclon expression for the identification and control of cancer cells |
02/12/2015 | US20150044198 Reduced-viscosity concentrated protein formulations |
02/12/2015 | US20150044168 Treatment of Multiple Sclerosis With Anti-CD19 Antibody |
02/12/2015 | US20150044164 Methods of Treating Autoimmune Diseases |
02/12/2015 | US20150044140 Protease-resistant compounds useful as shuttles through the blood-brain barrier and shuttle-cargo constructs |
02/12/2015 | US20150044137 Neutralizing antibodies to hiv-1 and their use |
02/12/2015 | US20150044136 Ophthalmological treatment for michobial infections |
02/12/2015 | US20150044134 Compositions, methods and kits for treatment of cancer and autoimmune diseases |
02/11/2015 | EP2835644A1 Nanocomposites for encapsulation of cells and method for treating diseases |
02/11/2015 | EP2835423A1 Ligase E3 RNF185 inhibitors and uses thereof |
02/11/2015 | EP2835379A1 Multi-functional antibody polypeptide for cryptic epitope of epidermal growth factor receptor and t cell antigen |
02/11/2015 | EP2834356A1 Recombinant bacterium for induction of cellular immune response |
02/11/2015 | EP2834274A1 Recombinant papaya mosaic virus coat proteins and uses thereof in influenza vaccines |
02/11/2015 | EP2834273A1 Bispecific antibodies against human tweak and human il17 and uses thereof |
02/11/2015 | EP2834271A1 Humanized and chimeric anti-factor bb antibodies and uses thereof |
02/11/2015 | EP2834265A1 Methods and compositions for dengue virus epitopes |
02/11/2015 | EP2834263A1 Epitope- scaffold immunogens against respiratory syncytial virus (rsv) |
02/11/2015 | EP2833915A1 Dosage and administration of monospecific and bispecific anti-igf-1r and anti-erbb3 antibodies |
02/11/2015 | EP2833914A1 Improved adjuvant system for oral vaccine adminstration |
02/11/2015 | EP2833913A1 Tolerisation- inducing composition |
02/11/2015 | EP2833912A1 Outer membrane proteins of histophilus somni and methods thereof |
02/11/2015 | EP2833911A2 Subunit vaccine delivery platform for robust humoral and cellular immune responses |
02/11/2015 | EP2833910A2 Pcv/mycoplasma hyopneumoniae combination vaccine |
02/11/2015 | EP2833909A1 Pcv/mycoplasma hyopneumoniae/prrs combination vaccine |
02/11/2015 | EP2833908A1 Mycoplasma hyopneumoniae vaccine |
02/11/2015 | EP2833907A2 Compositions and methods of inhibting masp-1 and/or masp-3 for the treatment of paroxysmal nocturnal hemoglobinuria |
02/11/2015 | EP2833903A1 Secretory immunoglobulin complex |
02/11/2015 | EP2833900A1 Extracellular matrix metalloproteinase inducer (emmprin) peptides and binding antibodies |
02/11/2015 | EP2833897A1 Method for the preparation of a strain- adapted vaccine |
02/11/2015 | CN104350070A 调节免疫反应的组合物和方法 Adjust the compositions and methods of immune response |
02/11/2015 | CN104350069A 中和rsv、mpv和pvm的抗体和其应用 And in rsv, mpv and pvm antibodies and their applications |
02/11/2015 | CN104350066A 施马伦贝格病毒(sbv)疫苗、其制备方法及用途 Schmallenberg virus (sbv) vaccine, their preparation and use |
02/11/2015 | CN104349791A 包含抗-dll4抗体的稳定化制剂 The stabilized preparation comprising antibodies anti -dll4 |
02/11/2015 | CN104349789A 分泌性免疫球蛋白复合物 Secretory immunoglobulin complexes |
02/11/2015 | CN104342453A 含基因工程抗体基因表达盒的微环dna重组母质粒、含该表达盒的微环dna及应用 Microring dna parent plasmid containing the genetically engineered recombinant antibody gene expression cassette, the expression cassette containing the microring dna and Applications |
02/11/2015 | CN104341530A Vnsak多肽及其应用 Vnsak peptide and its application |
02/11/2015 | CN104341529A 带有DARPin的双特异性嵌合蛋白 Bispecific chimeric protein with DARPin of |
02/11/2015 | CN104341506A 一种重组融合蛋白及其用途 A recombinant fusion protein and its use |
02/11/2015 | CN104341505A 对蒙古人种和高加索人种低免疫原性的、抗egfr的人鼠嵌合抗体 For Mongoloid and Caucasoid low immunogenicity, anti-human chimeric antibody egfr |
02/11/2015 | CN104341504A 双特异性抗体 Bispecific antibody |
02/11/2015 | CN104341503A 对蒙古人种和高加索人种低免疫原性的、抗cd20的人抗体 For Mongoloid and Caucasoid low immunogenicity, anti-human antibodies cd20 |
02/11/2015 | CN104341502A 低免疫原性抗TNF-α全人源单抗及其应用 Low immunogenicity fully human anti-TNF-α monoclonal antibody and its application |
02/11/2015 | CN104341501A 抗IL-1β人源化单克隆抗体及其制备方法和应用 Anti-IL-1β humanized monoclonal antibody and its preparation method and application |
02/11/2015 | CN104341500A 螯合淀粉样蛋白β肽的人源化抗体 Human amyloid β peptide chelating humanized antibody |
02/11/2015 | CN104341498A 抗血清、中和抗体、及含其的医药组合物 Antiserum, neutralizing antibodies, and pharmaceutical compositions containing it |
02/11/2015 | CN104338136A 用于治疗的gm-csf和il-17抑制剂 For the treatment of gm-csf and il-17 inhibitor |
02/11/2015 | CN104338135A 抑郁症的调节因子及其应用 Adjustment factor for depression and its application |
02/11/2015 | CN104338132A 一种病毒免疫治疗药物复合物及其用途 A virus immunotherapeutic drug complexes and uses thereof |
02/11/2015 | CN104338131A 芪黄肽多糖注射液 Qihuang polysaccharide peptide injection |
02/11/2015 | CN104338130A 芪黄肽注射液的制备方法 Qihuang peptide injection preparation |
02/11/2015 | CN104338129A 雷帕霉素作为疫苗佐剂的用途及制备方法 Use and preparation of rapamycin as a vaccine adjuvant |
02/11/2015 | CN104338128A 一种疫苗组合物及其制备方法和应用 A vaccine composition and preparation method and application |
02/11/2015 | CN104338127A 一种h9n2亚型禽流感灭活疫苗的生产方法及其制品 One kind of h9n2 subtype avian influenza inactivated vaccine production methods and products |
02/11/2015 | CN104338126A 一种具有治疗或预防hpv病毒的疫苗组合物及其应用 Having a vaccine composition for the treatment or prevention of hpv virus and its application |
02/11/2015 | CN104338125A 一种猪肺炎支原体抗原在预防和治疗猪呼吸道疾病综合征方面的应用 An hyopneumoniae antigen used in the prevention and treatment of swine respiratory syndrome |
02/11/2015 | CN104013958B 抗六种致病菌的特异性卵黄免疫球蛋白组合物及其制剂 Six kinds of pathogen-specific anti-immunoglobulin yolk composition and preparation |
02/11/2015 | CN103611157B 一种用作疫苗佐剂的竹节参皂苷及其制备方法与用途 For use as a vaccine adjuvant chikusetsu saponin and its preparation method and use |
02/11/2015 | CN103285385B 一种制备猪圆环病毒2型灭活疫苗的方法 A porcine circovirus type 2 inactivated vaccine prepared |
02/11/2015 | CN103275227B Axl抗体 Axl antibody |
02/11/2015 | CN103223165B 肿瘤细胞所导致的免疫抑制的解除剂及使用该解除剂的抗肿瘤剂 Immune suppression caused by tumor cells releasing agent using the releasing agent is an antitumor agent |
02/11/2015 | CN103157101B 副猪嗜血杆菌病、猪链球菌病二联灭活疫苗及其制备方法 Parasuis disease, Streptococcus suis two inactivated vaccine and its preparation method |
02/11/2015 | CN103045545B 一种脑炎病毒蛋白及其编码基因和应用 One kind of encephalitis virus protein and its encoding gene and application |
02/11/2015 | CN102827282B 人源抗Trop-2基因工程抗体IgG及其应用 Human anti-Trop-2 antibody IgG and its application of genetic engineering |
02/11/2015 | CN102675459B Thp蛋白单克隆抗体的制备方法 Preparation Thp monoclonal antibodies |
02/11/2015 | CN102573906B 抑免蛋白/亲环蛋白和emmprin免疫球蛋白受体超家族成员的双重抑制 Immunophilin / dual inhibition of cyclophilin protein and emmprin immunoglobulin receptor superfamily members |
02/11/2015 | CN102343089B 一种治疗乳癌的医药组成物 A method of treating breast cancer in a pharmaceutical composition |
02/11/2015 | CN101939335B 抗软骨退变的抗原结合多肽 Anti cartilage degeneration antigen binding polypeptide |